Mankind Pharma targets early Semaglutide launch

🇮🇳 Economic Times India (IN) —
Mankind Pharma targets early Semaglutide launch

AI Summary

Mankind Pharma is targeting an early launch of a Semaglutide-based product in India, aiming to compete in the rapidly growing GLP-1 weight loss and diabetes drug market. The move signals intensifying competition in the pharmaceutical sector for this blockbuster drug class.

Markets Deals Health Mankind Pharma Semaglutide GLP-1 pharma launch India weight loss drug diabetes

Read original source →